APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chronic Pain Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chronic Pain Treatment Market Outlook and Growth Opportunities 2026

21 December 2025198 pages

Choose your research edition.

Industry ResearchChronic Pain Treatment Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Pain Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Chronic Pain Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Pain Treatment Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Pain Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Chronic Pain Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chronic Pain Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chronic Pain Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Pain Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chronic Pain Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chronic Pain Treatment market include Sanofi, Johnson & Johnson, Novartis AG, Medtronic, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Boston Scientific Corporation and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Chronic Pain Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chronic Pain Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chronic Pain Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Chronic Pain Treatment market.

Chronic Pain Treatment Segment by Company

Sanofi

Johnson & Johnson

Novartis AG

Medtronic

Eli Lilly and Company

Pfizer

GlaxoSmithKline

Boston Scientific Corporation

Bristol-Myers Squibb

AstraZeneca PLC

Becton, Dickinson and Company

Abbott Laboratories

Chronic Pain Treatment Segment by Type

Drugs

Devices

Chronic Pain Treatment Segment by Application

Research Centers

Nursing Homes

Hospitals

Clinics

Chronic Pain Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Chronic Pain Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Chronic Pain Treatment key companies, revenue, market share, and recent developments.

3. To split the Chronic Pain Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Chronic Pain Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chronic Pain Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Chronic Pain Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Pain Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Pain Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Pain Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chronic Pain Treatment industry.

Chapter 3: Detailed analysis of Chronic Pain Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Chronic Pain Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Chronic Pain Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chronic Pain Treatment Industry Trends Table 2. Chronic Pain Treatment Industry Drivers Table 3. Chronic Pain Treatment Industry Opportunities and Challenges Table 4. Chronic Pain Treatment Industry Restraints Table 5. Global Chronic Pain Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chronic Pain Treatment Revenue Share by Company (2021-2026) Table 7. Global Chronic Pain Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Chronic Pain Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Chronic Pain Treatment Company, Product Type & Application Table 10. Global Chronic Pain Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Chronic Pain Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Drugs Table 15. Significant Companies of Devices Table 16. Global Chronic Pain Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Chronic Pain Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Chronic Pain Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Chronic Pain Treatment Sales Value Share by Type (2021-2026) Table 20. Global Chronic Pain Treatment Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Research Centers Table 22. Significant Companies of Nursing Homes Table 23. Significant Companies of Hospitals Table 24. Significant Companies of Clinics Table 25. Global Chronic Pain Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Chronic Pain Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Chronic Pain Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Chronic Pain Treatment Sales Value Share by Application (2021-2026) Table 29. Global Chronic Pain Treatment Sales Value Share by Application (2027-2032) Table 30. Global Chronic Pain Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Chronic Pain Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Chronic Pain Treatment Sales Value Share by Region (2021-2026) Table 33. Global Chronic Pain Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Chronic Pain Treatment Sales Value Share by Region (2027-2032) Table 35. Global Chronic Pain Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Chronic Pain Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Chronic Pain Treatment Sales Value Market Share by Country (2021-2026) Table 38. Global Chronic Pain Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Chronic Pain Treatment Sales Value Market Share by Country (2027-2032) Table 40. Sanofi Company Information Table 41. Sanofi Business Overview Table 42. Sanofi Chronic Pain Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Sanofi Chronic Pain Treatment Product Portfolio Table 44. Sanofi Recent Development Table 45. Johnson & Johnson Company Information Table 46. Johnson & Johnson Business Overview Table 47. Johnson & Johnson Chronic Pain Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Johnson & Johnson Chronic Pain Treatment Product Portfolio Table 49. Johnson & Johnson Recent Development Table 50. Novartis AG Company Information Table 51. Novartis AG Business Overview Table 52. Novartis AG Chronic Pain Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Novartis AG Chronic Pain Treatment Product Portfolio Table 54. Novartis AG Recent Development Table 55. Medtronic Company Information Table 56. Medtronic Business Overview Table 57. Medtronic Chronic Pain Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Medtronic Chronic Pain Treatment Product Portfolio Table 59. Medtronic Recent Development Table 60. Eli Lilly and Company Company Information Table 61. Eli Lilly and Company Business Overview Table 62. Eli Lilly and Company Chronic Pain Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Eli Lilly and Company Chronic Pain Treatment Product Portfolio Table 64. Eli Lilly and Company Recent Development Table 65. Pfizer Company Information Table 66. Pfizer Business Overview Table 67. Pfizer Chronic Pain Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Pfizer Chronic Pain Treatment Product Portfolio Table 69. Pfizer Recent Development Table 70. GlaxoSmithKline Company Information Table 71. GlaxoSmithKline Business Overview Table 72. GlaxoSmithKline Chronic Pain Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. GlaxoSmithKline Chronic Pain Treatment Product Portfolio Table 74. GlaxoSmithKline Recent Development Table 75. Boston Scientific Corporation Company Information Table 76. Boston Scientific Corporation Business Overview Table 77. Boston Scientific Corporation Chronic Pain Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Boston Scientific Corporation Chronic Pain Treatment Product Portfolio Table 79. Boston Scientific Corporation Recent Development Table 80. Bristol-Myers Squibb Company Information Table 81. Bristol-Myers Squibb Business Overview Table 82. Bristol-Myers Squibb Chronic Pain Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Bristol-Myers Squibb Chronic Pain Treatment Product Portfolio Table 84. Bristol-Myers Squibb Recent Development Table 85. AstraZeneca PLC Company Information Table 86. AstraZeneca PLC Business Overview Table 87. AstraZeneca PLC Chronic Pain Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. AstraZeneca PLC Chronic Pain Treatment Product Portfolio Table 89. AstraZeneca PLC Recent Development Table 90. Becton, Dickinson and Company Company Information Table 91. Becton, Dickinson and Company Business Overview Table 92. Becton, Dickinson and Company Chronic Pain Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Becton, Dickinson and Company Chronic Pain Treatment Product Portfolio Table 94. Becton, Dickinson and Company Recent Development Table 95. Abbott Laboratories Company Information Table 96. Abbott Laboratories Business Overview Table 97. Abbott Laboratories Chronic Pain Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Abbott Laboratories Chronic Pain Treatment Product Portfolio Table 99. Abbott Laboratories Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Chronic Pain Treatment Product Image Figure 2. Global Chronic Pain Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Chronic Pain Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Drugs Image Figure 8. Devices Image Figure 9. Global Chronic Pain Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Chronic Pain Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Chronic Pain Treatment Sales Value Share by Type (2021-2032) Figure 12. Research Centers Image Figure 13. Nursing Homes Image Figure 14. Hospitals Image Figure 15. Clinics Image Figure 16. Global Chronic Pain Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Chronic Pain Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Chronic Pain Treatment Sales Value Share by Application (2021-2032) Figure 19. Global Chronic Pain Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Chronic Pain Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Chronic Pain Treatment Sales Value (2021-2032) & (US$ Million) Figure 22. North America Chronic Pain Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Chronic Pain Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Chronic Pain Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Chronic Pain Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Chronic Pain Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Chronic Pain Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. South America Chronic Pain Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Chronic Pain Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Chronic Pain Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Chronic Pain Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Drugs
  • Devices
Applications
  • Research Centers
  • Nursing Homes
  • Hospitals
  • Clinics
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis AG
  • Medtronic
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • Boston Scientific Corporation
  • Bristol-Myers Squibb
  • AstraZeneca PLC
  • Becton, Dickinson and Company
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chronic Pain Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chronic Pain Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Chronic Pain Treatment Market Dynamics
  1. 2.1 Chronic Pain Treatment Industry Trends
  2. 2.2 Chronic Pain Treatment Industry Drivers
  3. 2.3 Chronic Pain Treatment Industry Opportunities and Challenges
  4. 2.4 Chronic Pain Treatment Industry Restraints
3 Chronic Pain Treatment Market by Company
  1. 3.1 Global Chronic Pain Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Chronic Pain Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Chronic Pain Treatment Company Ranking (2024-2026)
  4. 3.4 Global Chronic Pain Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Chronic Pain Treatment Company Product Type and Application
  6. 3.6 Global Chronic Pain Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Chronic Pain Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Chronic Pain Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Chronic Pain Treatment Market by Type
  1. 4.1 Chronic Pain Treatment Type Introduction
  2. 4.1.1 Drugs
  3. 4.1.2 Devices
  4. 4.2 Global Chronic Pain Treatment Sales Value by Type
  5. 4.2.1 Global Chronic Pain Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Chronic Pain Treatment Sales Value by Type (2021-2032)
  7. 4.2.3 Global Chronic Pain Treatment Sales Value Share by Type (2021-2032)
5 Chronic Pain Treatment Market by Application
  1. 5.1 Chronic Pain Treatment Application Introduction
  2. 5.1.1 Research Centers
  3. 5.1.2 Nursing Homes
  4. 5.1.3 Hospitals
  5. 5.1.4 Clinics
  6. 5.2 Global Chronic Pain Treatment Sales Value by Application
  7. 5.2.1 Global Chronic Pain Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Chronic Pain Treatment Sales Value by Application (2021-2032)
  9. 5.2.3 Global Chronic Pain Treatment Sales Value Share by Application (2021-2032)
6 Chronic Pain Treatment Regional Value Analysis
  1. 6.1 Global Chronic Pain Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chronic Pain Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Chronic Pain Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Chronic Pain Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chronic Pain Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Chronic Pain Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Chronic Pain Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Chronic Pain Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Chronic Pain Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Chronic Pain Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Chronic Pain Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Chronic Pain Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Chronic Pain Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Chronic Pain Treatment Sales Value Share by Country, 2025 VS 2032
7 Chronic Pain Treatment Country-level Value Analysis
  1. 7.1 Global Chronic Pain Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chronic Pain Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Chronic Pain Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Chronic Pain Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Chronic Pain Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Chronic Pain Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Chronic Pain Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Chronic Pain Treatment Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Chronic Pain Treatment Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis AG
  14. 8.3.1 Novartis AG Company Information
  15. 8.3.2 Novartis AG Business Overview
  16. 8.3.3 Novartis AG Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis AG Chronic Pain Treatment Product Portfolio
  18. 8.3.5 Novartis AG Recent Developments
  19. 8.4 Medtronic
  20. 8.4.1 Medtronic Company Information
  21. 8.4.2 Medtronic Business Overview
  22. 8.4.3 Medtronic Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Medtronic Chronic Pain Treatment Product Portfolio
  24. 8.4.5 Medtronic Recent Developments
  25. 8.5 Eli Lilly and Company
  26. 8.5.1 Eli Lilly and Company Company Information
  27. 8.5.2 Eli Lilly and Company Business Overview
  28. 8.5.3 Eli Lilly and Company Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eli Lilly and Company Chronic Pain Treatment Product Portfolio
  30. 8.5.5 Eli Lilly and Company Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Chronic Pain Treatment Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Chronic Pain Treatment Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Boston Scientific Corporation
  44. 8.8.1 Boston Scientific Corporation Company Information
  45. 8.8.2 Boston Scientific Corporation Business Overview
  46. 8.8.3 Boston Scientific Corporation Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boston Scientific Corporation Chronic Pain Treatment Product Portfolio
  48. 8.8.5 Boston Scientific Corporation Recent Developments
  49. 8.9 Bristol-Myers Squibb
  50. 8.9.1 Bristol-Myers Squibb Company Information
  51. 8.9.2 Bristol-Myers Squibb Business Overview
  52. 8.9.3 Bristol-Myers Squibb Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bristol-Myers Squibb Chronic Pain Treatment Product Portfolio
  54. 8.9.5 Bristol-Myers Squibb Recent Developments
  55. 8.10 AstraZeneca PLC
  56. 8.10.1 AstraZeneca PLC Company Information
  57. 8.10.2 AstraZeneca PLC Business Overview
  58. 8.10.3 AstraZeneca PLC Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca PLC Chronic Pain Treatment Product Portfolio
  60. 8.10.5 AstraZeneca PLC Recent Developments
  61. 8.11 Becton, Dickinson and Company
  62. 8.11.1 Becton, Dickinson and Company Company Information
  63. 8.11.2 Becton, Dickinson and Company Business Overview
  64. 8.11.3 Becton, Dickinson and Company Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Becton, Dickinson and Company Chronic Pain Treatment Product Portfolio
  66. 8.11.5 Becton, Dickinson and Company Recent Developments
  67. 8.12 Abbott Laboratories
  68. 8.12.1 Abbott Laboratories Company Information
  69. 8.12.2 Abbott Laboratories Business Overview
  70. 8.12.3 Abbott Laboratories Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Abbott Laboratories Chronic Pain Treatment Product Portfolio
  72. 8.12.5 Abbott Laboratories Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst